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Hyaluronan (hyaluronic acid, HA), a high-molecular-mass glycos-
aminoglycan, is an abundant component of the extracellular
matrix and pericellular coat. In embryonic tissue, it is believed to
contribute to the primordial, loose extracellular matrix, to enhance
cell migration and to modulate differentation (Pauli and Knudson,
1988; Toole, 1991; Turley, 1992). In neoplastic tissues, it presents
with several functions as a moderator of tumour cell adhesion,
migration and angiogenesis (Catterall et al, 1995; Rooney et al,
1995). Moreover, it has been suspected as functioning as a signal
that stimulates transformation, tumour growth and metastasis
(Pauli and Knudson, 1988; Catterall et al, 1995; Hall et al, 1995).
HA has at least two important receptors on the cell surface, CD44
and RHAMM (Rudzki and Jothy, 1997). The interaction between
CD44 and its main ligand HA is presumed to be associated with
HA degradation (Underhill, 1992) and invasive potential (Rudzki
and Jothy, 1997).
The stroma of most malignant tumours, including gastric cancer
(Sowa et al, 1989; Noguchi et al, 1993; Wang et al, 1996), contains
more HA than the corresponding normal tissue, although less is
known of the expression of HA in the cancer cells (Knudson,
1996). However, the methods used in some of the earlier studies
are less specific and cannot distinguish between HA derived from
tumour parenchyma and that from the surrounding stroma
(Knudson, 1996). Some gastric cancer cell lines are capable of
secreting HA in vitro (Sobue et al, 1983), whereas histological
analysis with a specific probe on a small number of cases
suggested low expression of HA in gastric carcinoma cells (Wang
et al, 1996).
As far as the authors are aware, there are no studies concerning
the relation between HA expression and tumour spread or survival
in gastric cancer, whereas several studies suggest that the HA
receptor CD44 is associated with invasion and prognosis (Hong et
al, 1995; Streit et al, 1996; M￿ller et al, 1997). The aim of the
present study was to assess HA expression in gastric adenocarci-
nomas in a large cohort, consisting of 215 patients, and to study
the association between HA expression and clinical and
histopathological characteristics of the tumours. In addition, the
prognostic significance of HA expression was evaluated in a long-
term follow-up.
PATIENTS AND METHODS
Patients
The study was based on 215 patients diagnosed and treated for
primary gastric cancer at Kuopio University Hospital between
1976 and 1988, and followed up until 1993. The clinical data were
obtained from the patient records. The location and size of the
tumour as well as the status of the regional lymph nodes and other
intra-abdominal organs were registered as described on gastro-
scopy, at operation and in examination of the resected stomach
(UICC, 1987). All patients were operated on, a total gastrectomy
was performed in 96 cases (45%), a subtotal gastrectomy in 77
cases (36%) and a gastric resection in 41 cases (19%). One patient
underwent only an explorative laparotomy. Additional treatment,
such as radiation therapy or chemotherapy was given to 11
patients. The causes of death were obtained from the patient
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Histological methods
The tumour samples were routinely fixed in 10% buffered
formalin and embedded in paraffin. Several original sections from
each of the primary tumours were re-examined and the most repre-
sentative tissue block was selected, cut at 5-mm thickness and
stained in haematoxylin and eosin (HE). The tumours were classi-
fied according to Laur￿n as diffuse, intestinal, mixed or unclassi-
fied (Laur￿n, 1965). All tumours except those of the diffuse type
were graded as well differentiated (grade I), moderately differenti-
ated (grade II) or poorly differentiated (grade III). The depth of
tumour invasion (UICC, 1987) and invasion into the walls of
veins, arteries and lymphatics, or into the perineural space was
registered in all samples which contained the full thickness of
gastric wall and graded as weak (+), moderate (++) or strong
(+++) (Set￿l￿ et al, 1996). The infiltration of lymphocytes and
plasma cells (TIL, tissue infiltrating lymphocytes) was estimated,
avoiding ulcerated or necrotic areas, and graded as weak,
moderate or strong.
Preparation of the biotinylated HA probe
The biotinylated hyaluronan binding complex (bHABC) was
prepared from bovine articular cartilage as described previously
(Wang et al, 1992; Tammi et al, 1994a). This probe contains the
biotinylated HA-binding G1 fragment of aggrecan and link
protein, which stabilizes the ternary complex with HA. Poly-
acrylamide gel electrophoresis of the probe showed only bands
corresponding to the HA-binding region of aggrecan and link
protein. The 5-mm-thick sections of the samples were deparaf-
finized in xylene and rehydrated in graded alcohols, followed by
washing in 0.1 M sodium phosphate buffer (PB), pH 7.4. The
endogenous peroxidase activity was blocked by washing the slides
with 0.3% hydrogen peroxide for 3 min and the non-specific
binding by incubation with 1% bovine serum albumin (BSA) in
PB for 30 min. The sections were then incubated overnight with
the bHABC (5 mg ml—1, diluted in 1% BSA) at 4¡C, washed with
PB and treated with avidin—biotin—peroxidase (Vector, Irvine, CA,
USA; 1:200 dilution) for 1 h at room temperature. After washes in
PB, the slides were incubated for 5 min in 0.05% 3,3¢-diamino-
benzidine (Sigma, St Louis, MC, USA) and 0.03% hydrogen
peroxide in PB at room temperature. After the washes, the sections
were counterstained and mounted in Depex.
Staining specificity was controlled by predigesting the sections
with Streptomyces hyaluronidase (Seikagagu, Tokyo, 100 TRU ml—1
in 0.1 M sodium acetate buffer, pH 5.0, for 3 h) in the presence of
protease inhibitors (Tammi et al, 1994b) and preincubating the
bHABC probe with hyaluronan oligosaccharides (Ripellino et al,
1985). No staining was observed in hyaluronidase or oligosaccha-
ride control sections (Figure 1E).
Assessment of HA staining
All samples were analysed by a pathologist (VMK) without
knowledge of other clinical or histological data. The staining
intensity in the tumour parenchyma and in the stroma around and
inside the malignant areas was registered as absent (—), weak (+),
moderate (++) or strong (+++) from the most representative tissue
section, using the ￿normal￿ weak staining of the stroma as an
internal positive control (Figure 1). The percentage of HA-positive
tumour cells of all neoplastic cells in the section was also
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Table 1 Clinicopathological data of the 215 gastric cancer patients
Depth of invasion
pT1 32 (15%)
pT2 37 (17%)
pT3 126 (59%)
pT4 19 (9%)
pTX 1
Size of the tumour
< 2 cm 22 (10%)
2–5 cm 48 (22%)
5–10 cm 59 (27%)
> 10 cm 41 (19%)
Not known 45 (21%)
Laurén classification
Diffuse 101 (47%)
Intestinal 85 (40%)
Mixed 20 (9%)
Unclassified 9 (4%)
Vascular invasion
Negative 195 (91%)
Positive 17 (8%)
Not assessed 3 (1%)
Perineural invasion
Negative 117 (54%)
Weak 71 (33%)
Strong 25 (12%)
Not assessed 2 (1%)
Nodal status
pN0 96 (45%)
pN1 88 (41%)
pN2 16 (7%)
pNX 15 (7%)
Location of the tumour
Proximal third 34 (16%)
Middle third 31 (14%)
Distal third 111 (52%)
More than one-third 38 (18%)
Not known 1
Differentiation grade
Grade I 28 (13%)
Grade II 54 (25%)
Grade III 29 (13%)
Not assessed 104 (48%)
TIL
Weak 126 (59%)
Moderate 64 (30%)
Strong 16 (7%)
Not assessed 9 (4%)
Lymphatic invasion
Negative 117 (54%)
Weak 61 (28%)
Strong 35 (16%)
Not assessed 2 (1%)
Metastasis
M0 181 (84%)
M1 26 (12%)
MX 8 (4%)
TIL, tumour-infiltrating lymphocytes and plasma cells.estimated. The fraction of positive tumour cells was primarily
analysed semiquantitatively in a continuous scale, but, for statis-
tical calculations, the percentage of tumours cells positive for HA
was categorized as seen in Table 2: 0%, <30% and ‡ 30%.
Statistical analysis
In basic statistical calculations, the SPSS-X program was used in
an IBM computer. Frequency distributions were tested by the chi-
squared test and Yate￿s correction was applied when appropriate.
The differences between the means of continuous variables were
tested by analysis of variance. The univariate survival analysis
(log rank analysis, SPSS-X) was based on the life-table method
with the statistics of Gehan (Kaplan and Meier, 1958). Multi-
variate survival analysis (Cox model, Cox, 1972) was carried out
with the SPSS-X program package in a stepwise manner, and
continuous variables were used as absolute numbers in this
analysis. Enter and removal limits were P † 0.05 and > 0.10
respectively.
RESULTS
Of the 215 patients, 125 were men and 90 women. The mean age
of the patients at the time of diagnosis was 66 years (s.d. 12, range
23—89) and the mean follow-up time 10 years (range 4—17). The
clinicopathological characteristics of the patients are presented in
Table 1.
The expression of HA in the non-neoplastic mucosa in the close
vicinity of the tumours was either totally negative or weakly posi-
tive. In all cases, the stromal tissue was HA positive (Table 2).
Some cases of diffuse-type cancer required careful examination
because the neoplastic cells were scattered among the strongly
stained stromal tissue, making the evaluation rather difficult. The
expression of HA in the tumour parenchyma is summarized in
Table 2. In only 15 carcinomas, the parenchyma was totally HA
negative, and most of the tumours (79%) showed moderate or
strong staining intensity of the neoplastic cells. The different posi-
tive staining patterns are illustrated in Figure 1.
The staining intensity of the peritumoral stroma was not associ-
ated with any of the examined clinical or histopathological
features, except for the fraction of stained cells in the tumour
(P<0.0001) and the staining intensity of the tumour parenchyma
(P< 0.0001)
The staining intensity in the tumour parenchyma was signifi-
cantly related to pT, as the staining was more intense in deeply
penetrating tumours (Table 3). However, no significant association
was found between staining intensity and pN or M. Strong
staining, as well as negative staining, was more often found among
the diffuse-type tumours, whereas the weakly stained tumours
were usually of the intestinal type (Table 3). Moderate or strong
staining intensity showed a strong association with poorly differ-
entiated tumours of the intestinal type.
The fraction of HA-stained tumour cells was significantly asso-
ciated with the depth of invasion, the presence of nodal metastases
and lymphatic invasion, as well as with differentiation grade as
shown in Table 4. HA expression was most frequent in the mixed
type of cancer, however without statistical significance. The frac-
tion of HA-positive cells was not significantly related to tumour
location, distant metastasis, vascular or perineural invasion or TIL
(data not shown).
As shown in Figure 2, the survival of the patients was directly
associated with the fraction of HA-stained tumour cells (P =
0.0025). In univariate survival analysis of curatively operated
stage I or II patients (n = 110), HA expression did not reach statis-
tical significance. When a multivariate analysis of 195 stage I—IV
patients was performed, including several clinical and histological
variables (pT, pN, M, size and location of the tumour, vascular,
lymphatic and perineural invasion, TIL, Laur￿n classification, and
the fraction of HA-stained cells and staining intensity in the
tumour and in the stroma), the independent predictors of survival
were pT [ratio of risk (RR) 2.04, 95% confidence interval (CI)
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Table 2 Hyaluronan expression in 215 gastric cancer patients
Staining No. of cases %
Stroma
Negative 0 0
Weakly positive 7 3
Moderately positive 42 20
Strongly positive 166 77
Tumour parenchyma
Negative 15 7
Weakly positive 30 14
Moderately positive 99 46
Strongly positive 71 33
The percentage of HA-positive cells
01 5 7
< 30 105 49
30–100 95 44
Mean fraction of HA-stained tumour cells is 32% (SD 29%)
Table 3 The association between clinicopathological variables and the HA-
staining intensity in the tumour parenchyma of 215 gastric cancer patients
Variable – + ++ +++ Statistics*
Depth of invasion
pT1 7 4 12 9 P = 0.002
pT2 2 12 15 8 c3 = 30.3
pT3 5 13 60 48
pT4 1 1 12 5
Nodal status
pN0 0 17 44 26 P = 0.61 (ns)
pN1 5 11 39 33 c2 = 7.2
pN2 1 1 7 7
Metastasis
M0 15 28 85 53 P = 0.066 (ns)
M1 0 2 9 15 c2 = 11.8
Laurén classification
Diffuse 10 7 37 47 P = 0.0002
Intestinal 4 20 43 18 c2 = 26.6
Mixed 0 1 13 6
Differentiation grade
Grade I 4 7 14 3 P = 0.010
Grade II 1 12 31 10 c2 = 16.7
Grade III 0 2 16 11
Tumour location
Proximal third 2 6 22 4 P = 0.015
Middle third 0 6 12 13 c2 = 20.4
Distal third 11 15 51 34
More than one-third 2 2 14 20
*Chi-squared test (Pearson).1.60—2.62], pN (RR 1.75, CI 1.45—2.11), and vascular (RR 2.56,
CI 1.49—4.40) and lymphatic invasion (RR 1.38, CI 1.10—1.74),
the P-value for all being †0.005.
DISCUSSION
The purpose of the present study was to investigate HA expression
in different types and stages of gastric adenocarcinoma and to reveal
possible associations with malignant behaviour of the tumours. The
results indicate that HA is expressed in the neoplastic epithelial cells
of most gastric carcinomas (93%), irrespective of the tumour type.
The expression of HA was more extensive in advanced cases with
deep penetration of the tumour cells in the gastric wall and with
nodal metastasis, features known to be associated with poor differ-
entiation grade (Set￿l￿ et al, 1996). The frequent abnormal expres-
sion of HA in advanced gastric cancer is comparable to the
expression of several other molecular abnormalities because the
overexpression of growth factor TGF-b and amplification of c-
erbB-2, K-sam and c-met are also often encountered in advanced
cases (Tahara, 1995). In addition, the expression of the epithelial
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Figure 1 Affinity histochemical staining for HA in human gastric cancer.
Samples with a weak (A), moderate (B) and strong (C) positive signal for HA
in intestinal type of cancer. The adjacent stroma was always positively
stained for HA (star, A). Scale bar = 50 mm. (D) A sample with diffuse type of
cancer shows strongly positive cancer cells (arrow). Scale bar = 20 mm.
(E) On the left, positive HA staining with cytoplasmic involvement in intestinal
type of cancer; on the right, same sample of negative control treated with
Streptomyces hyaluronidase before the staining. Scale bar = 20 mmisoform CD44E, containing products of exons v8—v10, or variant
CD44, containing v5, has been reported to be significantly associ-
ated with deep invasion, nodal metastasis, and lymphatic and
vascular invasion (M￿ller et al, 1997; Rudzki and Jothy, 1997),
whereas the expression of CD44v6 is associated with the extent of
the disease in the diffuse-type tumours only (Hong et al, 1995).
The current finding that invasion into deeper layers of the
gastric wall and to lymphatic structures is frequent in tumours rich
in hyaluronan may be explained by the capability of some tumour
cells to stimulate HA production in host fibroblasts, causing sepa-
ration of collagen layers and allowing cell migration and invasion
(Knudson et al, 1984). In addition, the cells expressing high levels
of HA are easily detached from the primary tumour and may form
tumour emboli, enhancing the formation of distant metastases
(Catterall et al, 1995). Moreover, the angiogenic effect of HA
oligosaccharides (Liu et al, 1996) may significantly enhance
cancer growth through tumour neovascularization, an important
predictor of disease outcome in gastric cancer (Maeda et al, 1995;
Tanigawa et al, 1996).
Significant differences have been reported in the expression of
adhesion molecules between the two main types of gastric cancer.
The expression of CD44 isoforms containing exons v5 and v6 is
more frequent in the intestinal type of cancer (Rudzki and Jothy,
1997), whereas the gene mutations of another adhesion molecule
E-cadherin are more prevalent in the diffuse-type cancer (Streit et
al, 1996). The above findings seem to be reasonable because the
diffuse-type cancer typically invades the gastric wall with single
cells or small clusters of cells, whereas the intestinal type is more
cohesive in nature (Laur￿n, 1965). We also hypothesized that we
would find more significant differences in the HA expression
between the two main types, but failed to do so. The mechanisms
behind the different modes of invasion obviously need to be
further investigated.
The reports on the relation between HA expression and survival
in adenocarcinomas are few so far. However, a recent study by
Ropponen et al (1998) found that HA intensity in tumour epithe-
lium was an independent predictor of survival in local colonic
adenocarcinoma, concluding that HA may have clinical impor-
tance as a prognostic factor in colon cancer. In gastric cancer, some
factors of tumour cell adhesion have been proposed to be signifi-
cant predictors of the disease outcome. The expression of standard
CD44 (CD44s) and isoforms containing exons v5 and v9 has been
associated with tumour recurrence and high mortality (Mayer et al,
1993; M￿ller et al, 1997), which is in line with our findings of HA.
However, further studies are needed to confirm the impact of
abnormal HA expression on survival.
In conclusion, the present study indicates that hyaluronan is
expressed in most gastric cancers. Strong HA-expression is signif-
icantly related to advanced tumour spread and short survival. From
the clinical point of view, the depth of invasion and nodal status
remain the most important independent predictors of survival in
gastric cancer. However, the present data provide further support
to the idea that hyaluronan is one of the key molecules involved in
the invasive growth of adenocarcinomas.
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